As future lines of research, we suggest to longitudinally evaluate the MFA in adults with CF to assess the prognostic value of different techniques (nutritional ultrasound, BIA, HGS), and evaluate how they may change with the use of CFTR modulators. This evidence concerns the gene CFTR and cystic fibrosis.